Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 26.73B | 69.74B | 26.12B | 26.33B | 25.14B | 23.65B |
Gross Profit | 47.78B | 28.66B | 27.31B | 27.07B | 23.29B | 23.55B |
EBITDA | 694.00M | 15.95B | 0.00 | 15.41B | 15.17B | 13.76B |
Net Income | 9.77B | 10.12B | 9.39B | 10.00B | 10.69B | 10.18B |
Balance Sheet | ||||||
Total Assets | 1.31T | 1.35T | 1.25T | 1.25T | 1.22T | 1.09T |
Cash, Cash Equivalents and Short-Term Investments | 82.78B | 55.50B | 47.32B | 108.01B | 120.31B | 88.52B |
Total Debt | 203.85B | 216.23B | 136.15B | 181.67B | 188.00B | 160.43B |
Total Liabilities | 1.23T | 1.28T | 1.18T | 1.18T | 1.14T | 1.01T |
Stockholders Equity | 75.26B | 78.78B | 73.09B | 71.63B | 72.83B | 78.68B |
Cash Flow | ||||||
Free Cash Flow | -36.43B | -2.46B | -48.57B | 6.78B | 20.68B | 12.54B |
Operating Cash Flow | -36.03B | -825.00M | -48.16B | 8.35B | 21.66B | 13.30B |
Investing Cash Flow | -480.00M | -329.00M | -1.11B | -15.74B | -96.76B | -38.79B |
Financing Cash Flow | 1.40B | 7.59B | -10.71B | -5.62B | 106.72B | 85.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $224.04B | 12.83 | 10.69% | 5.00% | -2.96% | -13.66% | |
77 Outperform | $262.14B | 13.81 | 11.51% | 2.09% | 0.37% | 19.89% | |
74 Outperform | $172.50B | 14.32 | 9.43% | 2.28% | 0.82% | 28.48% | |
74 Outperform | $142.56B | 9.94 | 12.85% | 2.44% | -14.74% | 17.03% | |
73 Outperform | $178.71B | 14.05 | 6.64% | 2.39% | 0.52% | 89.25% | |
68 Neutral | $18.06B | 11.97 | 10.24% | 3.74% | 9.75% | 1.30% | |
57 Neutral | $184.08B | 27.90 | 13.41% | 2.80% | 5.15% | 6.57% |